GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xcorporeal XCRP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Xcorporeal — daily XCRP Delayed
Market value
$1,460
Last close × shares
Volume
121.1k
Shares, 30 Oct 2026

About Xcorporeal

Its shares trade under the ticker XCRP. It has been listed since 29 February 2000. In the fiscal year to 31 December 2010, it reported revenue of $119 and a net loss of $4,236. At that date it held total assets of $28,000.

Xcorporeal, Inc. is a shell company which is engaged in the development of extracorporeal platform technology to be used in devices to replace the function of various human organs. The company is headquartered in Los Angeles, California. The company went IPO on 2000-02-29. The platforms lead to three initial products: portable artificial kidney (PAK), for attended care renal replacement therapy (RRT), for patients suffering from acute renal failure (ARF); a PAK for home hemodialysis for patients suffering from end stage renal disease (ESRD), and a wearable artificial kidney (WAK) for continuous ambulatory hemodialysis for treatment of ESRD.

Figures and description from our data supplier, not checked against the company's own report.

More about Xcorporeal →

Latest on Xcorporeal

Our reporting

We have not reported on Xcorporeal yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Xcorporeal's ticker?

Xcorporeal trades as XCRP on its US listing, under ISIN US98400P1049.

What was Xcorporeal's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.